PATIENT-LEVEL MISCONCEPTIONS AS DETERMINANTS OF ORAL HYPOGLYCEMIC AGENT USE: A CROSS-SECTIONAL ANALYSIS
DOI:
https://doi.org/10.22159/ijcpr.2026v18i2.8078Keywords:
Oral anti diabetic drugs, Type2 diabetes, Patient misconceptions, Drug utilization, Medication adherenceAbstract
Objective: To examine patient-level misconceptions related to oral hypoglycemic agent use and their association with treatment patterns using a cross-sectional analysis of outpatient data.
Methods: This cross-sectional study used an outpatient drug utilization survey involving adults with type 2 diabetes mellitus receiving OHAs, either alone or in combination with insulin. Patient-level misconceptions were inferred from reported medication-related behaviors that deviated from evidence-based diabetes management principles. Descriptive analyses were performed to assess the prevalence of identified misconception domains and their distribution across treatment patterns.
Results: Among 59 patients included in the analysis, treatment permanence misconceptions were observed in 27.1% of participants, while safety-related misconceptions were identified in 18.6%. Treatment permanence misconceptions were more common among patients receiving oral hypoglycemic agents alone compared with those receiving combined OHA–insulin therapy. Safety-related misconceptions were present in both treatment groups, but were more frequent among patients on OHA monotherapy.
Conclusion: Patient-level misconceptions regarding oral hypoglycemic agent use are common and vary according to treatment exposure. Addressing these misconceptions through patient-centered education and consistent counselling may be essential for promoting rational and sustained use of oral hypoglycemic agents in routine diabetes care.
Downloads
References
1. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern-PMC. Available from: https://pmc.ncbi.nlm.nih.gov/articles/pmc3977406. [Last accessed on 23 Feb 2026].
2. Ganesan K, Rana MB, Sultan S. Oral hypoglycemic medications. In: Treasure Island, FL: StatPearls Publishing; 2025. Available from: http://www.ncbi.nlm.nih.gov/books/NBK482386. [Last accessed on 23 Feb 2026].
3. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011 Apr;86(4):304–14. doi: 10.4065/mcp.2010.0575.
4. Zhang J, Hu J, Zheng Y, Dai T. Factors affecting medication adherence in patients with chronic diseases: a systematic literature review. Chinese Gen Pract J. 2025;2(3):100072. doi: 10.1016/j.cgpj.2025.100072.
5. Patil R, Nasrin AN, Datta SS, Boratne AV, Lokeshmaran. Popular misconceptions regarding the diabetes management: where should we focus our attention? J Clin Diagn Res. 2013 Feb;7(2):287-91. doi: 10.7860/JCDR/2013/4416.2749, PMID 23542645.
6. Religioni U, Barrios Rodriguez R, Requena P, Borowska M, Ostrowski J. Enhancing therapy adherence: impact on clinical outcomes, healthcare costs and patient quality of life. Medicina (Kaunas). 2025 Jan 17;61(1):153. doi: 10.3390/medicina61010153, PMID 39859135.
7. Joho AA, Sandi F, Yahaya JJ. Determinants of knowledge, attitude and practice among patients with type 2 diabetes mellitus: a cross-sectional multicenter study in Tanzania. PLOS Glob Public Health. 2023;3(12):e0001351. doi: 10.1371/journal.pgph.0001351, PMID 38039284.
8. Babak A, Rouzbahani S, Safaeian A, Poonaki F. Diabetes mellitus type 2 and popular misconceptions: a cross-sectional study. Health Sci Rep. 2025 Oct 3;8(10):e71308. doi: 10.1002/hsr2.71308, PMID 41049880.
9. Kilic B, Oz MN. Beliefs about medications health anxiety and educational impact on treatment adherence in type 2 diabetes: a cross-sectional study. Med (Baltim). 2025 Aug 15;104(33):e43930. doi: 10.1097/MD.0000000000043930, PMID 40826722.
10. Rezaei M, Valiee S, Tahan M, Ebtekar F, Ghanei Gheshlagh R. Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study. Diabetes Metab Syndr Obes. 2019 May 1;12:589-99. doi: 10.2147/DMSO.S197159, PMID 31118722.
11. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011 May;26(3):155-9. doi: 10.5001/omj.2011.38, PMID 22043406.
12. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016 Jul 22;10:1299-307. doi: 10.2147/PPA.S106821, PMID 27524885.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Dr Sophia B Modi, Dr Sunilkumar G
This work is licensed under a Creative Commons Attribution 4.0 International License.